-

Maya Dimitrova1, Jeffrey Weber

  • 1From the Laura and Isaac Perlmutter Comprehensive Cancer Center, NYU Grossman School of Medicine, New York, NY.

PubMed
概括

用免疫检查点抑制剂治疗转移性黑色素瘤已经取得显著进展,改善了患者的生存率. 本综述涵盖了目前的免疫疗法选择和转移性黑色素瘤的临床决策.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K